Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies

Lymphoproliferative Disorders trial results

NCT05080166

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Hefei, Anhui, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Guangzhou, Guangdong, China
  • Research Site Nanning, Guangxi, China
View all 14 locations
Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations
  • St Luke's Hospital Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Augsburg Augsburg, Germany
View all 14 locations
Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 102 locations
Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Centre hospitalier Universitaire de Limoges - Limoges, France
  • University Hospital Heidelberg Heidelberg, Germany
  • General Hospital of Athens "Alexandra" Athens, Greece
  • Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy
Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States